Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia

Completed · Phase 2

Conditions studied: Head and Neck Cancer, Lung Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of zileuton may be an effective way to prevent lung cancer in patients who have bronchial dysplasia. PURPOSE: Randomized phase II trial to study the effectiveness of zileuton in preventing lung cancer in patients who have bronchial dysplasia.

Key facts

Study ID

NCT00056004

Run by

Barbara Ann Karmanos Cancer Institute

People needed

38

Starts

2003-06-01

Expected to finish

2009-03-01

Last updated by the study team

2013-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.